Skip to main content
. 2024 Apr 29;8(16):4294–4310. doi: 10.1182/bloodadvances.2023010973

Figure 3.

Figure 3.

Relapse and survival outcomes. (A) OS. (B) Progression-free survival. (C) GRFS. (D) Moderate-severe CFS. (E) Cumulative incidence of nonrelapse mortality competing with relapse. (F) Cumulative incidence of relapse competing with death. ∗P value for differences in survival estimates obtained from log-rank test; P value for differences in cumulative incidence obtained using Gray method.